Streetbeat News

Revenues

BA

Boeing's 2024 Commercial Market Outlook (CMO) predicts that China's commercial aircraft fleet will double by 2043 due to the expansion and modernization of the aviation industry.

Portfolio Pulse from Benzinga Newsdesk

August 27, 2024 | 6:28 am

EWG

Germany's GDP for Q2 decreased by 0.1%, matching estimates and down from a 0.2% increase in the previous quarter. This economic data could impact the iShares MSCI Germany ETF (EWG), which tracks the performance of the German equity market.

Portfolio Pulse from Benzinga Newsdesk

August 27, 2024 | 6:17 am

AEM

GDX

GLDM

GOLD

IAU

IAUM

NEM

Gold prices are nearing a new record high, with a significant rise in gold mining stocks and ETFs. The VanEck Gold Miners ETF (GDX) and other gold-related ETFs have seen substantial gains this year. Experts predict continued positive trends for gold prices.

Portfolio Pulse from Benzinga Neuro

August 27, 2024 | 6:17 am

EWG

Germany's GDP for Q2 remained flat at 0.0% year-over-year, which is slightly better than the estimated -0.1% and an improvement from the previous -0.2%. This indicates a stabilization in Germany's economic performance.

Portfolio Pulse from Benzinga Newsdesk

August 27, 2024 | 6:17 am

EWG

The GfK Consumer Climate index for Germany in September has decreased to -22 from a revised -18.6 in the previous period, indicating a decline in consumer sentiment.

Portfolio Pulse from Benzinga Newsdesk

August 27, 2024 | 6:02 am

ACB

CGC

TLRY

Aurora Cannabis Inc. (NASDAQ:ACB) has partnered with Vectura Fertin Pharma to launch a CBD lozenge, potentially boosting sales by 31%. Aurora's international sales have increased, and the company maintains a strong financial position with a focus on innovative healthcare solutions.

Portfolio Pulse from Nicolás Jose Rodriguez

August 27, 2024 | 1:51 am

NRXP

HOPE Therapeutics, a subsidiary of NRx Pharmaceuticals, plans to acquire a network of ketamine treatment clinics with $30 million in financing. The expansion aims to treat conditions like depression and PTSD, projecting $100 million in annual revenue by 2025.

Portfolio Pulse from Rolando García

August 26, 2024 | 10:48 pm

TOL

Toll Brothers (NYSE:TOL) has outperformed the market over the past 10 years with an average annual return of 15.06%, surpassing the market by 4.23% annually. A $1000 investment in TOL 10 years ago would now be worth $4,066.80.

Portfolio Pulse from Benzinga Insights

August 26, 2024 | 9:30 pm

DFS

Discover Financial Services (NYSE:DFS) has significantly outperformed the market over the past 15 years, with an average annual return of 16.72%. A $1000 investment in DFS 15 years ago would now be worth $9,653.82, highlighting the power of compounded returns.

Portfolio Pulse from Benzinga Insights

August 26, 2024 | 9:30 pm

LFCR

Lifecore Biomedical has announced its financial expectations for fiscal year 2025, projecting revenue between $126.5 million and $130 million, and adjusted EBITDA between $19 million and $21 million.

Portfolio Pulse from Benzinga Newsdesk

August 26, 2024 | 9:29 pm